Spots Global Cancer Trial Database for loperamide
Every month we try and update this database with for loperamide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients | NCT04038619 | Colitis Diarrhea Malignant Genit... Melanoma Lung Cancer Ovarian Cancer Uterine Cancer Breast Cancer Cervical Cancer | Fecal Microbiot... Loperamide | 18 Years - | M.D. Anderson Cancer Center | |
| A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas | NCT00401388 | Chondrosarcomas Alveolar Soft P... Extra Skeletal ... | Perifosine Loperamide Allopurinol Antiemetics | 13 Years - | AEterna Zentaris | |
| A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies | NCT04172597 | Breast Cancer Colorectal Canc... Solid Tumor Glioblastome Mu... | Poziotinib Hydr... Loperamide | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study | NCT02266849 | Rectal Cancer Ulcerative Coli... Short Bowel Syn... | Loperamide Placebo | 18 Years - | Odense University Hospital | |
| Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib | NCT05252988 | Early-stage Bre... HER2 Positive B... Hormone Recepto... | Neratinib Loperamide Colesevelam | 18 Years - | Spanish Breast Cancer Research Group | |
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread | NCT02057133 | Breast Neoplasm... | LY2835219 Letrozole Anastrozole Tamoxifen Exemestane Everolimus Trastuzumab LY3023414 Fulvestrant Pertuzumab Loperamide Endocrine thera... | 18 Years - | Eli Lilly and Company | |
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread | NCT02057133 | Breast Neoplasm... | LY2835219 Letrozole Anastrozole Tamoxifen Exemestane Everolimus Trastuzumab LY3023414 Fulvestrant Pertuzumab Loperamide Endocrine thera... | 18 Years - | Eli Lilly and Company | |
| ADAM-Afatinib Diarrhea Assessment and Management | NCT01814553 | Carcinoma, Non-... | afatinib loperamide | 18 Years - | Boehringer Ingelheim | |
| A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib | NCT04366713 | HER2 Amplified ... | Neratinib Capecitabine Loperamide | 18 Years - | Puma Biotechnology, Inc. | |
| A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib | NCT04366713 | HER2 Amplified ... | Neratinib Capecitabine Loperamide | 18 Years - | Puma Biotechnology, Inc. | |
| Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study | NCT02266849 | Rectal Cancer Ulcerative Coli... Short Bowel Syn... | Loperamide Placebo | 18 Years - | Odense University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
